Literature DB >> 7832235

Increased numbers of mast cells in pterygia.

S I Butrus1, M F Ashraf, D M Laby, A I Rabinowitz, S O Tabbara, A A Hidayat.   

Abstract

PURPOSE/
METHODS: We examined the mast cells in 12 pterygium specimens of patients who underwent primary excisions and the conjunctival specimens of ten normal age-matched control subjects. RESULTS/
CONCLUSION: The mean mast cell count per cubic millimeter was twice as high in the pterygium specimens as in the control specimens. Mast cell proliferation and activation may contribute to the pathogenesis of pterygium formation.

Entities:  

Mesh:

Year:  1995        PMID: 7832235     DOI: 10.1016/s0002-9394(14)73882-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

Review 1.  Ocular mast cells. Characterization in normal and disease states.

Authors:  E B Cook; J L Stahl; N P Barney; F M Graziano
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

2.  Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium.

Authors:  L Mastropasqua; P Carpineto; M Ciancaglini; P Enrico Gallenga
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

3.  Epidemiology and recurrence rate of pterygium post excision in Ghanaians.

Authors:  V A Essuman; C T Ntim-Amponsah; G K Vemuganti; T A Ndanu
Journal:  Ghana Med J       Date:  2014-03

Review 4.  Developments and current approaches in the treatment of pterygium.

Authors:  Dilek Hacıoğlu; Hidayet Erdöl
Journal:  Int Ophthalmol       Date:  2016-09-23       Impact factor: 2.031

5.  Overexpression of fractalkine and its histopathological characteristics in primary pterygium.

Authors:  Meydan Turan; Gulay Turan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-21       Impact factor: 3.117

6.  The use of antimetabolites as adjunctive therapy in the surgical treatment of pterygium.

Authors:  Alyaà Abood Kareem; Qasim Kadhim Farhood; Hussein Ali Alhammami
Journal:  Clin Ophthalmol       Date:  2012-11-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.